In this excerpt from the new book ‘Speak Data,’ the Wharton professor and best-selling author shares his thoughts on how we interpret and communicate information Data is an omnipresent facet of modern ...

The infrastructure requirement for America’s AI overhaul is fostering the breaking of bread across partisan lines in the hinterlands.

Thousands of climate protesters marched through the Brazilian city of Belem on Saturday in a noisy, diverse and peaceful ...

As artificial intelligence moves deeper into healthcare, executive teams are grappling with how to make it operational, safe, and sustainable. During the AI Summit at Becker’s 13th Annual CEO+CFO ...

Each year, the European Lung Foundation (ELF) recognises outstanding research that advances patient-centred care and promotes ...

Merck’s enlicitide decanoate significantly reduced LDL-C in adults with heterozygous familial hypercholesterolemia in phase 3 CORALreef HeFH trial: Rahway, New Jersey Tuesday, N ...

The prevailing assumption is that executives only need high-level briefings, not practical AI training. That's wrong.

When a mother is anaemic during pregnancy, her child is more likely to be born premature, underweight and with iron ...

Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...

Detailed price information for Mirum Pharmaceuticals Inc (MIRM-Q) from The Globe and Mail including charting and trades.

Whereas academics and intellectuals tend to be a timid bunch, going along to get along, Sowell has consistently and confidently gone his own way.

The lower number of second primary tumors in the cemiplimab arm appeared to be due to a small number of patients with multiple second primary tumors in the placebo arm.